KÃ¥re Schultz
Infectious diseases
Activas Bulgaria Co
Bulgaria
Biography
Kåre Schultz became Teva's President and CEO on November 1, 2017. Mr. Schultz, 56, is a seasoned veteran in the healthcare industry who has distinguished himself through his experience leading financial and restructuring initiatives at global companies. Since 2015 and until October 31, 2017 he has served as the President and Chief Executive Officer of H. Lundbeck A/S, which he joined as the company was facing the loss of critical patents. Mr. Schultz conducted a top to bottom evaluation of the business and implemented a robust turnaround strategy that involved cutting operating costs while targeting new product launches.
Research Interest
Infectious diseases
